Skip to main content
Stem Cell Research & Therapy logoLink to Stem Cell Research & Therapy
. 2022 Apr 13;13:166. doi: 10.1186/s13287-022-02842-y

Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7

Ruijie Zhang 1,#, Peng Li 2,#, Heli Lv 2, Nana Li 3, Suliang Ren 2, Wentao Xu 2,
PMCID: PMC9008958  PMID: 35418150

Retraction Note: Stem Cell Research & Therapy (2021) 12:349 10.1186/s13287-021-02393-8

The Editors-in-Chief have retracted this article at the request of the Corresponding Author.

After publication, the authors identified flaws in the study design and the data.

Further assessment of the article identified the following issues:

  • The number of tumor cells inoculated into mice for the xenograft experiment was higher than recommended by internationally accepted standards.

  • In Fig. 2d, the western blot image backgrounds and empty spaces in lane 1 appear remarkably similar.

  • In Fig. 6c and d, a number of tumor images appear remarkably similar.

In addition, the authors were unable to locate the original ethics approval documents.

The Editors-in-Chief therefore no longer have confidence in the presented data and the conclusions of this article.

All authors agree to this retraction.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Ruijie Zhang and Peng Li contributed equally to this work


Articles from Stem Cell Research & Therapy are provided here courtesy of BMC

RESOURCES